机构:[1]Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai, China[2]Department of Oncology Shanghai Medical College Fudan University Shanghai, China[3]Endoscopy Center and Endoscopy Research Institute Zhongshan Hospital Fudan University Shanghai, China[4]Department of Gastroenterology Guangzhou First People’s Hospital School of Medicine South China University of Technology Guangzhou, Guangdong, China[5]Singlera Genomics (Shanghai) Ltd Shanghai, China[6]Department of Pathology Nanfang Hospital Southern Medical University Guangzhou, China[7]Endoscopy Center and Endoscopy Research Institute Zhongshan Hospital Fudan University Shanghai, China
第一作者机构:[1]Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai, China[2]Department of Oncology Shanghai Medical College Fudan University Shanghai, China
通讯作者:
通讯机构:[1]Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai, China[2]Department of Oncology Shanghai Medical College Fudan University Shanghai, China[7]Endoscopy Center and Endoscopy Research Institute Zhongshan Hospital Fudan University Shanghai, China[*1]Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, 180 FengLin Road, Shanghai 200032, China
推荐引用方式(GB/T 7714):
Cai GuoXiang,Cai Mingyan,Feng Zhiqiang,et al.A multi-locus blood-based assay targeting circulating tumor DNA methylation enables early detection and early relapse prediction of colorectal cancer.[J].Gastroenterology.2021,doi:10.1053/j.gastro.2021.08.054.
APA:
Cai GuoXiang,Cai Mingyan,Feng Zhiqiang,Liu Rui,Liang Li&Zhou Pinghong.(2021).A multi-locus blood-based assay targeting circulating tumor DNA methylation enables early detection and early relapse prediction of colorectal cancer..Gastroenterology,,
MLA:
Cai GuoXiang,et al."A multi-locus blood-based assay targeting circulating tumor DNA methylation enables early detection and early relapse prediction of colorectal cancer.".Gastroenterology .(2021)